AzTrials
AzTrials

FearNCT07379021

Mindfulness-Based Emotion Regulation Training for Hospitalized Children

A study testing training in people with Fear and Child, Only, run by Ataturk University at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Hospitalization and medical procedures are a significant source of stress and anxiety for school-age children aged 7-11, who, due to their cognitive development, can perceive events but lack the capacity to cope effectively. Read more about this study

Who is it for?
Ages 7 to 11 yearsHealthy volunteers can take part
Conditions the study is for
Fear, Child, Only, Hospitalism in Children
What is being tested?
training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
54 participants
Where
1 siteTurkey (Türkiye)
Study dates
26 Dec 2025to 26 Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 11 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Be aged between 7 and 11 years old,
  • Have a planned hospital stay of at least four days,
  • Be able to speak and understand Turkish,
  • Be able to read and write (to complete questionnaires),
  • The child and parent must be willing to participate in the study.

Who cannot join

  • The child has a hearing/speech problem that prevents them from communicating,
  • The child has severe pain or acute respiratory distress that prevents them from participating,
  • The child has a known psychiatric diagnosis,
  • The child has previously received similar mindfulness training

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Turkey (Türkiye)1 site, 1 recruiting
  • Ataturk University Nursing of Faculty

    Erzurum

    ARZU SARIALIOGLU, 04422315795, arzu.celebi@atauni.edu.tr

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Mindfulness-Based Emotion Regulation Training on Fear and Emotion Regulation in Hospitalized Children

Hospitalization and medical procedures are a significant source of stress and anxiety for school-age children aged 7-11, who, due to their cognitive development, can perceive events but lack the capacity to cope effectively. The main objective of this project is to examine the effect of Mindfulness-Based Emotion Regulation Training, which will be applied to children aged 7-11 hospitalized in the pediatric clinic, on developing children's emotion regulation skills and reducing their fear levels related to the hospital. The research is a randomized controlled trial to be conducted between April 2026 and April 2027. Data will be collected using the "Child and Parent Introduction Form," the "Emotion Regulation Scale for Children and Adolescents," and the "Medical Procedure Fear Scale." While distraction techniques frequently used in the literature offer a quick and effective solution at the time of the procedure, this project differs in that it aims to provide children with sustainable emotion regulation skills that they can use not only at that moment but also in later stages of the illness and in future life events. As a result of the project, it is expected that the implemented training will increase adaptive emotion regulation strategies in children, significantly reduce medical fear and anxiety, and provide an evidence-based nursing intervention that will facilitate children's compliance with treatment.

Read the detailed description

The main objective of this project is to examine the effect of Mindfulness-Based Emotion Regulation Training, which will be applied to children aged 7-11 hospitalized in the pediatric clinic, on developing children's emotion regulation skills and reducing their fear levels related to the hospital. The research is a randomized controlled trial to be conducted between April 2026 and April 2027. Data will be collected using the "Child and Parent Introduction Form," the "Emotion Regulation Scale for Children and Adolescents," and the "Medical Procedure Fear Scale." While distraction techniques frequently used in the literature offer a quick and effective solution at the time of the procedure, this project differs in that it aims to provide children with sustainable emotion regulation skills that they can use not only at that moment but also in later stages of the illness and in future life events. As a result of the project, it is expected that the implemented training will increase adaptive emotion regulation strategies in children, significantly reduce medical fear and anxiety, and provide an evidence-based nursing intervention that will facilitate children's compliance with treatment.

Control Group: Children in the control group will not receive any mindfulness training from the researcher; only the clinic's routine nursing care and treatment procedures will be applied.

  • T1 (Pre-test): Scales will be administered on the first day of admission, prior to routine care.
  • T2 (Post-Test): Scales will be administered again on the 5th day of hospitalisation to complete data collection. Completing the forms will take an average of 15-20 minutes.

Intervention Group: Children in the intervention group will receive the 'Mindfulness-Based Emotion Regulation Training Programme' developed by the researcher in addition to routine nursing care.

  • T1 (Pre-test): Scales will be administered on the first day of admission, before the first training session.
  • Application: For 5 consecutive days, once a day, structured sessions (breathing exercises, emotion recognition, body scan, etc.), each lasting approximately 20 minutes, will be conducted in the child's own room with tablet/visual material support and under the guidance of the researcher. During the application, the quietness of the environment and the child's attention will be maintained in a standard manner.
  • T2 (Post Test): At the end of the 5th day (after the final session), the scales will be re-administered to evaluate the programme's effectiveness. Completing the forms will take an average of 15-20 minutes.
Being tested
training

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • trainingBehavioural

    In addition to routine nursing care, children in the intervention group will receive the 'Mindfulness-Based Emotion Regulation Training Programme' developed by the researcher.

Study groups in NCT07379021
Study groupRoleWhat they receive
trainingExperimentalIn addition to routine nursing care, children in the intervention group will receive the 'Mindfulness-Based Emotion Regulation Training Programme' developed by the researcher. * T1 (Pre-test): On the first day of admission, the scales will be administered before the first training session. * Application: For 5 consecutive days, once a day, structured sessions (breathing exercises, emotion recognition, body scan, etc.), each lasting approximately 20 minutes, will be conducted in the child's own room with tablet/visual material support and under the guidance of a researcher. During the application, the quietness of the environment and the child's attention will be maintained in a standard manner. * T2 (Post Test): At the end of the 5th day (after the final session), the scales will be re-administered to evaluate the programme's effectiveness. Completing the forms will take an average of 15-20 minutes.
Receives: Behavioral: training
controlNo interventionChildren in the control group will not receive any mindfulness training from the researcher; only the clinic's routine nursing care and treatment procedures will be applied. * T1 (Pre-test): Scales will be administered on the first day of admission, prior to routine care. * T2 (Post-Test): Scales will be administered again on the 5th day of hospitalisation to complete data collection. Completing the forms will take an average of 15-20 minutes.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Emotion Regulation Scale for Children and Adolescents:

    The scale was adapted by Gullone and Taffe (2012) from the Emotion Regulation Scale developed by Gross and John (2003) for an adult sample. The scale was adapted into Turkish by Tetik and Önder in 2021. The scale is a self-assessment tool designed to evaluate differences in the use of two emotion regulation strategies. The scale includes statements such as 'I control my emotions by not showing them.' The scale consists of 'two subscales, reappraisal and suppression, and 10 items.' The assessment is conducted using a 5-point Likert-type rating scale. Items 1, 3, 5, 7, 8, and 10 represent the reappraisal subscale, while items 2, 4, 6, and 9 represent the suppression subscale. High scores on the subscales indicate frequent use of the emotion regulation strategy represented by that subscale. The Cronbach's alpha internal consistency coefficient ranged from .82 to .86 for the reappraisal subscale and from .69 to .79 for the suppression subscale.

    Measured: 1 year

  2. Medical Procedure Fear Scale

    Developed by Marion Bloom et al. in 1985, this scale measures children's fears related to medical procedures and treatments. The validity and reliability study of the scale in Turkey was conducted by Alak (1993). The scale contains items such as 'I am afraid the doctor will hurt me' and 'I am afraid of going to the hospital' and is a 3-point Likert scale (0 = Never, 1 = Sometimes, 2 = Very much). Medical fears are addressed in 29 questions. The scale consists of four sub-dimensions. The Cronbach's alpha for the scale was found to be 0.93. The minimum score obtainable from the scale is 29, and the maximum score is 87. An increase in score indicates an increase in medical fear.

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jan 2026
  2. Study start26 Dec 2025
  3. Primary completion26 Dec 2026 (estimated)
  4. Study completion26 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
54 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07379021
Sponsor's protocol ID
30.2.ATA.0.01.00
Status last verified
Jan 2026
First submitted
23 Jan 2026
Last updated
30 Jan 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: There is not a plan to make IPD available.

Questions about this trial

What is this clinical trial studying?

A study testing training in people with Fear and Child, Only, run by Ataturk University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 30 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Emotion Regulation Scale for Children and Adolescents: (time frame: 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in